Clinical Trials Directory

Trials / Completed

CompletedNCT01832493

Sensor Optimization of Cardiac Resynchronization Therapy Response

Sensor Optimization of CRT Response

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Sensor Optimization of Cardiac Resynchronization Therapy (CRT) Response (SOCR) Study is a multicenter, prospective, non-randomized acute feasibility study that is being conducted to determine if subcutaneous heart sounds and/or intracardiac impedance can acutely identify the optimal atrioventricular (AV) pacing intervals and optimal left ventricular (LV) electrodes in patients indicated for cardiac resynchronization therapy.

Conditions

Interventions

TypeNameDescription
DEVICECardiac Resynchronization TherapyAll study patients were evaluated for the optimal atrial-ventricular (AV) programmed interval using various methods.

Timeline

Start date
2013-07-01
Primary completion
2016-01-01
Completion
2016-06-01
First posted
2013-04-16
Last updated
2016-08-29
Results posted
2016-08-29

Locations

9 sites across 4 countries: United States, Canada, Hong Kong, United Kingdom

Source: ClinicalTrials.gov record NCT01832493. Inclusion in this directory is not an endorsement.

Sensor Optimization of Cardiac Resynchronization Therapy Response (NCT01832493) · Clinical Trials Directory